• NAT10–ac4C Regulation in Mouse Oocyte Maturation

  2026-08-27

  The reference study identifies NAT10-mediated N4-acetylcytidine (ac4C) as a post-transcriptional regulator associated with mouse oocyte maturation in vitro. By combining NAT10 knockdown, maturation assays, RNA immunoprecipitation sequencing, and RNA pulldown, the authors connect reduced ac4C with delayed polar body extrusion and nominate TBL3 as a potential ac4C-binding protein.

• Quinolone–Coumarin Hybrids Against T. gondii

  2026-08-27

  A 2024 Acta Parasitologica study evaluated 12 quinolone–coumarin hybrids derived from fluoroquinolone antibacterials and novobiocin against intracellular Toxoplasma gondii. QC1, QC3, QC6, and novobiocin combined reduced parasite-associated infection, proliferation, and plaque formation with limited effects on healthy cells, identifying selective in vitro leads rather than clinically validated treatments.

• Cisplatin as a Probe of DNA Repair–m6A Crosstalk

  2026-08-26

  Cisplatin and CDDP can do more than quantify cytotoxicity: they can function as perturbational probes of DNA repair competence. This article translates new findings on METTL14–SMN control of m6A homeostasis into a rigorous framework for apoptosis assays, cancer research, and chemotherapy resistance studies.

• Berbamine Hydrochloride: NF-κB Research Guide

  2026-08-26

  Berbamine hydrochloride is a research compound used to investigate STAT3, calcium homeostasis, and NF-κB signaling pathway inhibition. Product benchmarks include time-dependent cytotoxicity in the leukemia cell line KU812 and activity in hepatocellular carcinoma HepG2 cells, while current HCC ferroptosis evidence supports a separate METTL16-SENP3-LTF mechanism.

• Purmorphamine: Smoothened Agonist Research Guide

  2026-08-25

  Purmorphamine is a synthetic Smoothened agonist for controlled Hedgehog pathway studies. Its reported activity includes alkaline phosphatase induction in C3H10T1/2 cells and Smo-linked olfactory effects in honeybees.

• Prion-Based Mutagenesis and Rapid Adaptation

  2026-08-25

  The Cell study shows that prion-like self-assembly can reversibly and heritably tune DNA repair and recombination, changing mutagenesis and adaptive trajectories under strong selection. Its cross-species experiments connect protein-based epigenetic memory with accelerated drug resistance while identifying prion-maintenance machinery as a potential control point.

• THZ1: A Covalent CDK7 Inhibitor Workflow

  2026-08-24

  THZ1 combines nanomolar CDK7 potency with irreversible covalent engagement, making it useful for dissecting transcriptional control, cancer-cell dependence, and treatment persistence. This guide translates its mechanism into practical dose-response, Pol II phosphorylation, apoptosis, and T-ALL workflows while highlighting controls that distinguish pathway biology from compound-handling artifacts.

• Fingolimod (FTY720): A Mechanism-First Guide

  2026-08-24

  Fingolimod (FTY720) is more than an oral multiple sclerosis therapy: it is a powerful tool for separating lymphocyte trafficking, CNS signaling, and cell-intrinsic toxicity in translational assays. This guide connects S1P biology with magnetic CAR-T-mimicking cell research while defining practical experimental boundaries.

• Neuroligin 1 Proteolysis Sustains Social Memory

  2026-08-23

  The reference study identifies social interaction-induced proteolysis of Neuroligin 1 as a mechanism that maintains, rather than merely forms, short-term social memory. Its findings connect α- and γ-secretase activity in the ventral hippocampus to an intracellular NLG1 fragment, cofilin signaling, dendritic spine remodeling, and behavioral memory persistence.

• Machine-Learning Discovery of Senolytics

  2026-08-22

  The reference study shows that cost-effective machine-learning models trained only on published data can identify senolytic candidates despite small and heterogeneous screening datasets. Computational screening followed by human-cell validation identified ginkgetin, periplocin, and oleandrin, demonstrating a practical route for reducing early-stage drug-discovery costs while retaining experimental confirmation.

• Diclofenac in Intestinal Organoids: Assay Logic

  2026-08-22

  Diclofenac is a non-selective COX inhibitor for dissecting prostaglandin biology in human intestinal organoid models. This article presents an assay-design framework that separates direct cyclooxygenase pharmacology from barrier, metabolism, and transport effects.

• Exemestane Workflows for Aromatase Assays

  2026-08-21

  Build reproducible aromatase, microsome, and cell-based assays around Exemestane’s irreversible mechanism rather than relying on a single endpoint. This workflow connects estrogen depletion, biomarker context, and washout experiments for stronger breast cancer research conclusions.

• Promethazine HCl: Macrophage Assay Workflows

  2026-08-20

  Promethazine HCl provides a practical probe for connecting histamine H1 receptor antagonism with macrophage ROS, autophagy, and intracellular antibacterial assays. This workflow-focused guide explains how to separate host-directed effects from cytotoxicity or direct bacterial inhibition while extending the compound into inflammation research and receptor signaling studies.

• BIRB 796 Workflow for p38α MAPK Research

  2026-08-20

  BIRB 796 (Doramapimod) combines subnanomolar p38α engagement with an allosteric mechanism suited to inflammation, cytokine, and apoptosis workflows. This guide translates its biochemical profile into practical cell-based assays, arthritis-model planning, and troubleshooting strategies while incorporating emerging evidence on p38α dephosphorylation.

• Recent Advances in Ibuprofen and Naproxen Synthesis

  2026-08-19

  Ha and Paek’s 2021 review maps important advances in the preparation of ibuprofen and naproxen, emphasizing shorter routes, asymmetric synthesis, improved practicality, and continuous-flow chemistry. Its main value is not a single replacement reaction, but a framework for evaluating how stereochemical control, process safety, scalability, and derivative design influence modern nonsteroidal anti-inflammatory drug research.

8530 records 1/569 page Next 12345 下5页 Last page